🔗 Permalink

Inventor profile of:

Lothar Steidler

City:

Lokeren

Country:

Belgium

Published Applications:

Last publication date:

2024-03-14

Top Assignees for applications by Lothar Steidler

The entities that hold a legal rights for patent applications filed by inventor Steidler Lothar:

INTREXON ACTOBIOTICS NV 18 ZWIJNAARDE, Belgium
Actogenix NV 3 Zwijnaarde, Belgium
INTREXON ACTOBIOTICS NV d/b/a Precigen Actobio 1 Zwijnaarde, Belgium
Vlaams Interuniversitair Instituut voor Biotechnologie 1 , Belgium
Actogenix NV 1 , Belgium
The United States of America, as represented by the Secretary, National Institute of Health 1 Rockville, MD United States

Recent patent applications by Steidler Lothar

Lothar Steidler from Lokeren, BE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-14

US20240082323A1

Human necessities

Compositions and methods for the treatment of type 1 diabetes

#2 | 2023-11-02

US20230348918A1

Chemistry; metallurgy

Genetically Modified Bacteria Stably Expressing IL-10 and Insulin

#3 | 2023-01-19

US20230013523A1

Chemistry; metallurgy

Mucoadhesive microorganism

#4 | 2022-10-27

US20220340621A1

Chemistry; metallurgy

TREATMENT OF CELIAC DISEASE

#5 | 2021-06-17

US20210180072A1

Chemistry; metallurgy

Genetically modified bacteria stably expressing IL-10 and insulin

#6 | 2021-06-03

US20210163961A1

Chemistry; metallurgy

POLYCISTRONIC EXPRESSION SYSTEM FOR BACTERIA

#7 | 2021-05-27

US20210154247A1

Human necessities

Compositions and methods for the treatment of type 1 diabetes

#8 | 2021-03-11

US20210070815A1

Chemistry; metallurgy

Mucoadhesive microorganism

#9 | 2020-05-28

US20200165564A1

Chemistry; metallurgy

Modified gram positive bacteria and uses thereof

#10 | 2019-09-26

US20190292551A1

Chemistry; metallurgy

Genetically modified bacteria stably expressing IL-10 and insulin

#11 | 2019-06-27

US20190194267A1

Chemistry; metallurgy

Mucoadhesive microorganism

#12 | 2019-01-24

US20190022154A1

Human necessities

Compositions and methods for the treatment of type 1 diabetes

#13 | 2018-08-23

US20180237739A1

Chemistry; metallurgy

Modified gram positive bacteria and uses thereof

#14 | 2018-07-05

US20180187203A1

Chemistry; metallurgy

Polycistronic expression system for bacteria

#15 | 2016-12-29

US20160376574A1

Chemistry; metallurgy

Modified gram positive bacteria and uses thereof

#16 | 2016-05-19

US20160137971A1

Chemistry; metallurgy

Modified gram positive bacteria and uses thereof

#17 | 2014-08-21

US20140234371A1

Chemistry; metallurgy

Modified gram positive bacteria and uses thereof

#18 | 2014-08-14

US20140227229A1

Chemistry; metallurgy

Modified gram positive bacteria and uses thereof

#19 | 2014-04-17

US20140105863A1

Chemistry; metallurgy

Polycistronic expression system for bacteria

#20 | 2013-06-27

US20130164380A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS

#21 | 2012-07-19

US20120183503A1

Chemistry; metallurgy

LACTOBACILLUS AND STREPTOCOCCUS PROMOTERS AND USES THEREOF

#22 | 2011-06-23

US20110150850A1

Chemistry; metallurgy

REDUCED COLONIZATION OF MICROBES AT THE MUCOSA

#23 | 2007-05-31

US20070122427A1

Chemistry; metallurgy

Delivery of trefoil peptides

#24 | 2007-05-22

US10030390

Delivery of trefoil peptides

#25 | 2007-05-17

US20070110723A1

Chemistry; metallurgy

Delivery of trefoil peptides

InventorID:

311666 ⎘